Proteimax ^{For Profit}

Proteimax was founded in 2001 in Sao Paulo, Brazil by leading scientists, Prof. Emer S. Ferro and Andrea Sterman Heimann. Their initial goal was to develop a method of screening, identifying, and commercializing antibodies and naturally occurring peptides, which are small proteins, for the pharmaceutical industry and basic research.